Biogen Inc (NASDAQ:BIIB)
| 264.80 Delayed Data As of Oct 22 |  -5.41 / -2.00%Today’s Change | 223.25 Today|||52-Week Range 468.55 | +8.14% Year-to-Date |
Latest BIIB News | Press Releases
Today’s Trading
| Previous close | 270.21 |
| Today’s open | 269.38 |
| Day’s range | 264.44 - 269.66 |
| Volume | 41,345 |
| Average volume (3 months) | 1,208,002 |
| Market cap | $38.9B |
Data as of 4:00pm ET, 10/22/2021
Growth & Valuation
| Earnings growth (last year) | -21.00% |
| Earnings growth (this year) | -43.51% |
| Earnings growth (next 5 years) | +3.00% |
| Revenue growth (last year) | -2.82% |
| P/E ratio | 25.3 |
| Price/Sales | 3.20 |
| Price/Book | 3.77 |
Competitors
Data as of 4:00pm ET, 10/22/2021
Financials
| Next reporting date | January 27, 2022 |
| EPS forecast (this quarter) | $3.32 |
| Annual revenue (last year) | $12.4B |
| Annual profit (last year) | $4.0B |
| Net profit margin | 32.38% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Cambridge, Massachusetts |
Forecasts
